205 related articles for article (PubMed ID: 32212266)
21. mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disorders.
Hirabayashi M; Chambers JK; Tani A; Tomiyasu H; Motegi T; Rimpo K; Nakayama H; Uchida K
Vet Comp Oncol; 2022 Sep; 20(3):587-601. PubMed ID: 35278028
[TBL] [Abstract][Full Text] [Related]
22. Survivin suppressor (YM155) enhances chemotherapeutic efficacy against canine histiocytic sarcoma in murine transplantation models.
Yamazaki H; Takagi S; Hosoya K; Okumura M
Res Vet Sci; 2015 Apr; 99():137-44. PubMed ID: 25744435
[TBL] [Abstract][Full Text] [Related]
23. Canine histiocytic neoplasia: an overview.
Fulmer AK; Mauldin GE
Can Vet J; 2007 Oct; 48(10):1041-3, 1046-50. PubMed ID: 17987966
[TBL] [Abstract][Full Text] [Related]
24. A review of histiocytic diseases of dogs and cats.
Moore PF
Vet Pathol; 2014 Jan; 51(1):167-84. PubMed ID: 24395976
[TBL] [Abstract][Full Text] [Related]
25. Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells.
Yamazaki H; Takagi S; Hosoya K; Okumura M
Vet J; 2015 Sep; 205(3):375-80. PubMed ID: 26048444
[TBL] [Abstract][Full Text] [Related]
26. Whole exome and transcriptome analysis revealed the activation of ERK and Akt signaling pathway in canine histiocytic sarcoma.
Asada H; Tani A; Sakuma H; Hirabayashi M; Matsumoto Y; Watanabe K; Tsuboi M; Yoshida S; Harada K; Uchikai T; Goto-Koshino Y; Chambers JK; Ishihara G; Kobayashi T; Irie M; Uchida K; Ohno K; Bonkobara M; Tsujimoto H; Tomiyasu H
Sci Rep; 2023 May; 13(1):8512. PubMed ID: 37231193
[TBL] [Abstract][Full Text] [Related]
27. Effect of dasatinib in a xenograft mouse model of canine histiocytic sarcoma and in vitro expression status of its potential target EPHA2.
Ito K; Miyamoto R; Tani H; Kurita S; Kobayashi M; Tamura K; Bonkobara M
J Vet Pharmacol Ther; 2018 Feb; 41(1):e45-e48. PubMed ID: 28833247
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinases expression in spontaneous canine histiocytic sarcomas and its xenograft model.
Fayyad A; Lapp S; Risha E; Pfankuche VM; Rohn K; Barthel Y; Schaudien D; Baumgärtner W; Puff C
Vet Immunol Immunopathol; 2018 Apr; 198():54-64. PubMed ID: 29571518
[TBL] [Abstract][Full Text] [Related]
29. A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies.
Takada M; Parys M; Gregory-Bryson E; Vilar Saavedra P; Kiupel M; Yuzbasiyan-Gurkan V
BMC Cancer; 2018 Mar; 18(1):237. PubMed ID: 29490634
[TBL] [Abstract][Full Text] [Related]
30. Variations in Histiocytic Differentiation of Cell Lines From Canine Cerebral and Articular Histiocytic Sarcomas.
Thongtharb A; Uchida K; Chambers JK; Nakayama H
Vet Pathol; 2017 May; 54(3):395-404. PubMed ID: 28178429
[TBL] [Abstract][Full Text] [Related]
31. Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups.
Egan C; Nicolae A; Lack J; Chung HJ; Skarshaug S; Pham TA; Navarro W; Abdullaev Z; Aguilera NS; Xi L; Pack S; Pittaluga S; Jaffe ES; Raffeld M
Haematologica; 2020 Apr; 105(4):951-960. PubMed ID: 31439678
[TBL] [Abstract][Full Text] [Related]
32. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs.
Affolter VK; Moore PF
Vet Pathol; 2002 Jan; 39(1):74-83. PubMed ID: 12102221
[TBL] [Abstract][Full Text] [Related]
33. Atypical disseminated histiocytic sarcoma in a 7-month-old dog.
Garcia-Torres M; Muñoz BS; Segalés J; Mallol C; Sanz A; López MC; Roura X
Vet Clin Pathol; 2024 Mar; 53(1):122-130. PubMed ID: 38242688
[TBL] [Abstract][Full Text] [Related]
34. Morphological Distinction of Histiocytic Sarcoma from Other Tumor Types in Bernese Mountain Dogs and Flatcoated Retrievers.
Erich SA; Constantino-Casas F; Dobson JM; Teske E
In Vivo; 2018; 32(1):7-17. PubMed ID: 29275293
[TBL] [Abstract][Full Text] [Related]
35. Multifocal cutaneous histiocytic sarcoma in a young dog and review of histiocytic cell immunophenotyping.
Mastrorilli C; Spangler EA; Christopherson PW; Aubry OA; Newton JC; Smith AN; Kennis RA; Weismann JL; Moore PF
Vet Clin Pathol; 2012 Sep; 41(3):412-8. PubMed ID: 22747712
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological characteristics of histiocytic sarcoma affecting the central nervous system in dogs.
Toyoda I; Vernau W; Sturges BK; Vernau KM; Rossmeisl J; Zimmerman K; Crowe CM; Woolard K; Giuffrida M; Higgins RJ; Dickinson PJ
J Vet Intern Med; 2020 Mar; 34(2):828-837. PubMed ID: 31919895
[TBL] [Abstract][Full Text] [Related]
37. Cytopathological diagnosis of visceral histiocytic sarcoma in five dogs.
Sapierzyński R; Jagielski D; Dolka I; Fabisiak M
Pol J Vet Sci; 2012; 15(4):751-8. PubMed ID: 23390766
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors Associated with Development of Histiocytic Sarcoma in Bernese Mountain Dogs.
Ruple A; Morley PS
J Vet Intern Med; 2016 Jul; 30(4):1197-203. PubMed ID: 27160025
[TBL] [Abstract][Full Text] [Related]
39. Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia.
Paulsson K; Horvat A; Strömbeck B; Nilsson F; Heldrup J; Behrendtz M; Forestier E; Andersson A; Fioretos T; Johansson B
Genes Chromosomes Cancer; 2008 Jan; 47(1):26-33. PubMed ID: 17910045
[TBL] [Abstract][Full Text] [Related]
40. RNA in situ hybridisation as a molecular diagnostic technique targeting IBA-1 and CD204 in canine histiocytic sarcoma.
Engelien JL; Lejeune AT; Dark MJ; Milner RJ; Shiomitsu K
Vet Med Sci; 2022 Jul; 8(4):1400-1408. PubMed ID: 35339118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
